On CNBC's “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management, LLC, picked American Express Company (NYSE:AXP).



On the earnings front, American Express reported upbeat first-quarter 2026 results on April 23. The company reported quarterly revenue (net of interest expense) growth of 10% year-over-year to $18.91 billion, topping the analyst consensus estimate of $18.62 billion. 



Higher Card Member spending drove the increase, along with higher net interest income, growth in card balances and strong card fee growth.



Don't forget to check out our premarket coverage here



Rob Sechan, CEO of NewEdge Wealth, named Eli Lilly and Company (NYSE:LLY) as his final trade.



According to recent news, Eli Lilly announced on June 9 that the U.S. Food and Drug Administration has approved the company's EBGLYSS (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis.



Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said Live Nation Entertainment, Inc. (NYSE:LYV) is on the verge of a new 52-week high.



Morgan Stanley analyst Cameron Mansson-Perrone, on Wednesday, maintained Live Nation Entertainment with an Overweight rating and raised the price target from $185 to $200.



<h2>Price Action</h2>



<ul>
<li>Eli Lilly shares gained 2.2% to close at $1,160.95 on Thursday.</li>



<li>American Express shares rose 1.6% to settle at $318.49 during the session.</li>



<li>Live Nation shares climbed 2.9% to close at $172.33 on Thursday.</li>
</ul>



Photo via Shutterstock

LLYX

LLYZ

ELIS

ELIL

CNBC's 'Final Trades' highlights American Express, Eli Lilly, and Live Nation. American Express reported strong Q1 2026 earnings with revenue beating estimates. Eli Lilly received FDA approval for its atopic dermatitis drug EBGLYSS. Live Nation is nearing a 52-week high after Morgan Stanley raised its price target to $200. All three stocks saw gains on Thursday.

benzinga_article

American Express

Eli Lilly

Live Nation

Defiance Daily Target 2X Long LLY ETF

Defiance Daily Target 2X Short LLY ETF

Direxion Daily LLY Bear 1X Shares

Direxion Daily LLY Bull 2X Shares

Morgan Stanley

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades'